PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Immunology programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University Health System (NUHS), National University of Singapore, Singapore.\', \'Infectious Diseases programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University Health System (NUHS), National University of Singapore, Singapore.\', \'Public Health Agency of Sweden, Stockholm, Sweden.\', \'Department of Laboratory Medicine, Karolinska Institute, Huddinge, Sweden.\', \'National Public Health Laboratory (NPHL), National Centre for Infectious Diseases (NCID), Singapore.\', \'Department of Biological Sciences (DBS), National University of Singapore, Singapore.\', \'Bioinformatics Institute (BII), A*STAR (Agency for Science, Technology and Research), Singapore.\', \'Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research), Singapore.\', \'Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University Health System (NUHS), National University of Singapore, Singapore.\', \'National Veterinary Institute, Uppsala, Sweden.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2807/1560-7917.ES.2020.25.28.2000291
?:hasPublicationType
?:journal
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
is ?:pmid of
?:pmid
?:pmid
  • 32700671
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all